Executive Decision Making - 2019

Celebrating 17 Years of Advancing Biopharma R&D Innovation, Decision Making and Operations

A conference for people at the intersection of science, business & operations…

In an environment of declining revenues and uncertain commercial success, biopharma, device and R&D companies must continuously optimize their strategy, evaluate their portfolios, improve decision making, reduce risk and effectively deploy resources. Cambridge Healthtech Institute and the BioPharma Strategy Series present a full week of high-level content, interactive discussions and networking at the 2nd Annual “Strategic and Operational Challenges of Immuno-Oncology Drug Development” (Mon-Tues), a “Project Portfolio Management (PPM) Master Class” (Mon-Tues), 17th Annual “Strategic Resource Management” (Wed-Thurs), and 14th Annual “Portfolio Management” (Thurs-Fri). (see Conference At-A-Glance)

Cambridge Healthtech Institute’s annual executive forum brings together R&D executives from the biopharma community to share best practices in project and portfolio management, R&D innovation, decision analysis, forecasting, resource management and immuno-oncology drug development. Delegates will gain strategic insights, proven tools, methods, and perspectives from a variety of leaders at the intersection of science, business and operations.